Diagnostic Test Accuracy Protocol
Biomarkers for assessing disease activity in inflammatory bowel disease
Editorial Group: Cochrane IBD Group
Published Online: 25 NOV 2013
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Mosli M, Fahmy M, Garg SK, Feagan SG, Baker KA, Zou GY, MacDonald JK, Sandborn WJ, Chande N. Biomarkers for assessing disease activity in inflammatory bowel disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010848. DOI: 10.1002/14651858.CD010848.
- Publication Status: New
- Published Online: 25 NOV 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
The primary objective is to determine the diagnostic accuracy of three commonly studied biomarkers (serum CRP, FC and SL) for assessing disease activity in patients with established IBD (i.e. UC or CD) presenting with symptoms suggestive of active disease.
A secondary objective is to investigate sources of heterogeneity by disease type (i.e. UC or CD), disease severity (e.g. mild, moderate or severe disease), disease location (e.g. distal or proximal involvement) and age.